Vaccine Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
HIV/AIDS
Research from N. Kiwanuka and co-researchers provides new data on HIV/AIDS
April 30th, 2008
According to recent research from Entebbe, Uganda, "Human immunodeficiency virus type 1 (HIV-1) subtypes differ in biological characteristics that may affect pathogenicity. We determined the HIV-1 subtype-specific rates of disease progression among 350 HIV-1 seroconverters." "Subtype, viral load, and CD4(+) cell count were determined. Cox proportional hazards regression modeling was used to estimate adjusted hazard ratios (HRs) of progression to acquired immunodeficiency syndrome (AIDS) (defined as a CD4(+) cell count of <= 250 cells/mm(3)) and to AIDS-associated death. A total of 59.1% of study subjects had subtype D strains, 15.1% had subtype A, 21.1% had...
Source: Vaccine Weekly (2008-04-30)
|
